Axovant’s use of twitter, facebook, linkedin and social media
Axovant is a user of Twitter and other social media properties and maintains a corporate Twitter account using the screen name: @Axovant, a Facebook page with a username: @axovant, and a LinkedIn page.
Axovant recognizes the importance of social media, including Twitter, Facebook, and LinkedIn, and new communication channels that enable Axovant to engage in interactive discussion. As a clinical-stage biopharmaceutical company, Axovant is committed to abide by the legal, ethical and regulatory standards applicable to the Company. Axovant aims to have responsible social interactions.
Axovant may respond to questions and comments presented via Twitter, Facebook, LinkedIn, and other social media properties, when appropriate. Axovant may not be able to immediately respond to questions or comments, and responses, if any, may be limited in nature.
There may be questions and/or comments Axovant cannot address, including, but not limited to, questions related to non-public confidential information, proprietary information, financial matters, ongoing legal matters, regulatory issues and other aspects of Axovant’s business. Axovant will not respond to rumors, personal attacks, foul language, disparaging comments or topics that do not relate directly to Axovant.
Twitter accounts that Axovant follows or is followed by do not indicate an endorsement of the account owner or their products and services.
Axovant may provide links or references to external websites, not controlled by Axovant, as part of its Tweets or posts. However, Axovant does not endorse or claim responsibility for the content of such other websites. Any links or references to such external websites are provided as merely a convenience to the users of the Twitter platform.
Axovant reserves all rights relating to the Axovant Twitter account (@Axovant), Axovant Facebook page (@Axovant), Axovant LinkedIn page, and its other social media properties including, but not limited to, all rights to add, remove or modify any content or material posted on the account, discontinue the account, accept or reject those who may wish to follow the account and respond to, or refrain from responding to, any questions or comments addressed to the account.